A lesson in how not to roll out real-time CGM to an existing system
What impact does a botched rollout of an app update have on a CGM provider?
Blog Posts
Continuous Ketone Monitoring – a world’s first from SiBio?
The world’s first Continuous Ketone Monitor from SiBio. What does it do and how relevant is it to diabetes?
And another one? The final poor CGM Smartwatch
As they go, this one looks quite smart, and appears to be running a slightly different operating system to all of the others that I’ve […]
Glastonbury 2023: Rick Astley and The Blossoms play the Smiths…
Which seems like a suitable metaphor for a field test of an experimental algorithm that doesn’t require mealtime bolusing and uses stepcount to mediate how […]
Novo Nordisk acquisition of Biocorp. A big deal in the Smartpen world?
Novo Nordisk’s acquisition of Biocorp demonstrates how insulin manufacturers are looking to take the next step in optimising insulin delivery, opening up better access to AI techniques for MDI users.
Non-invasive CGM watches. Is this a Dreamcatcher moment?
Another non-invasive CGM in a Smartwatch shows off its wares.
It turned out to be as bad as you’d expect.
Experiments with stepcounts. An n=1 experience
Learning about step counts as an input in AID systems. What does and doesnt work, and what could be better?
Cheap smartwatches with CGM… What do we think?
Trying out a smartwatch with non-invasive glucose monitoring. This isnt the watch you’re looking for….
Everybody’s moving – integrating stepcounts into Open Source Automated Insulin Delivery
Using activity data to change behaviour in AID systems.
Glucagon me… n=1 experiments with microbolusing glucagon part 2: quantifying use
Are two hormones and an algorithm enough? Or is diabetes far more complex than that?